Market revenue in 2023 | USD 11.8 million |
Market revenue in 2030 | USD 19.9 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 46.61% in 2023. Horizon Databook has segmented the China cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
The country is expected to witness the highest growth in Asia Pacific region over the forecast period owing to huge unmet needs of the huge population in the country. In addition, healthcare reforms in China are expected to drive the market in the near future. China is one of the fastest-growing economies in the world and it was the world's second largest medical devices market in 2017.
Moreover, increasing focus of the government on increasing the number of hospitals and rising healthcare expenditure in the country are expected to propel the demand for cannulas over the forecast period. For instance, as per International Trade Administration (ITA), in 2016, the number of hospitals in China was nearly 27,360 (23,900 public & 3,460 private). In addition, the total healthcare expenditure in the country was USD 663.0 billion, which accounted for 6.0% of China’s GDP.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account